The provided text is an excerpt from a Wikipedia article focusing on Dexcom, Inc., an American healthcare company specializing in continuous glucose monitoring (CGM) systems for diabetes management. It offers a comprehensive overview, including key company data such as its public trading status, financial figures from 2024, and its headquarters in San Diego. The source thoroughly outlines the company's history, tracing the development and FDA approvals of its various CGM systems, from the initial STS to the most recent G7 device. Additionally, the text details Dexcom's numerous partnerships with other healthcare and tech companies, its venture capital arm called Dexcom Ventures, and its recognition, such as being named a Nasdaq-100 component.